The abstract is read at the publisher; the summary is JClub's.
The WDR4 variant rs8130270 is linked to prostate cancer susceptibility, with an OR of 0.89 in the PLCO discovery cohort and validation in PRACTICAL.
- Why it matters: Genetic links between m7G-related gene variants and prostate cancer risk are unclear, limiting understanding of which regulators may shape susceptibility.
- What they did: Logistic regression tested rs8130270 in PLCO and PRACTICAL, followed by functional annotation, eQTL and RNA-structure analyses, expression and survival analyses, and single-cell transcriptomics.
- The result: The rs8130270 C allele is associated with lower WDR4 expression in prostate tissue, while higher WDR4 expression in prostate cancer is linked to poorer overall survival (HR = 1.67).
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.